Cover image for Biomaterials for spinal surgery
Title:
Biomaterials for spinal surgery
Series:
Woodhead Publishing in materials
Publication Information:
Cambridge, UK : Philadelphia, PA : Woodhead Publishing Ltd., 2012
Physical Description:
xvii, 622 p. : ill. ; 24 cm.
ISBN:
9781845699864

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010301567 R857 B56 2012 Open Access Book Book
Searching...

On Order

Summary

Summary

There have been important developments in materials and therapies for the treatment of spinal conditions. Biomaterials for spinal surgery summarises this research and how it is being applied for the benefit of patients.

After an introduction to the subject, part one reviews fundamental issues such as spinal conditions and their pathologies, spinal loads, modelling and osteobiologic agents in spinal surgery. Part two discusses the use of bone substitutes and artificial intervertebral discs whilst part three covers topics such as the use of injectable biomaterials like calcium phosphate for vertebroplasty and kyphoplasty as well as scoliosis implants. The final part of the book summarises developments in regenerative therapies such as the use of stem cells for intervertebral disc regeneration.

With its distinguished editors and international team of contributors, Biomaterials for spinal surgery is a standard reference for both those developing new biomaterials and therapies for spinal surgery and those using them in clinical practice.


Author Notes

Luigi Ambrosio is Director of the Institute for Composite and Biomedical Materials, National Research Council of Italy. Elizabeth Tanner is Professor of Biomedical Materials at the University of Glasgow, UK. Both are noted for their research in born" biomaterial and therapies.


Table of Contents

M. G. Raucci and A. Gloria, R and De Santis and L. Ambrosio, Institute of Composite and Biomedical Materials, National Research Council of Italy, Italy and K. E. Tanner, University of Glasgow, UKB. Alcock, SwitzerlandM. Quaye and J. Harvey, Queen Alexandra Hospital, UKH.J. Wilke, Institute of Orthopaedic Research and Biomechanics, University of Ulm, Germany and A. Rohlmann, Julius Wolff Institute, Charité - Universitatsmedizin Berlin, GermanyJ. Noailly and D. Lacroix, Institute for Bioengineering of Catalonia, SpainV. Mohan and M. C. Gupta, University of California, Davis Medical Center, USAG. Logroscino and L. Proietti and E. Pola, Catholic University of Rome, ItalyA. Gloria and R. De Santis and L. Ambrosio, Institute of Composite and Biomedical Materials, National Research Council of ItalyItaly and K. E. Tanner, University of Glasgow, UKP. A. Revell, UCL Eastman Dental Institute, UKD. Baxter, Royal Army Medical Corps, UK and J. Yeh, The Royal London Hospital, UKK. E. Tanner, University of Glasgow, UKT. W. Bauer, The Cleveland Clinic, USAC. Persson and H. Engqvist, Uppsala University, SwedenS. E. Maclaine and A. J. Bennett, University of Glasgow, UKM. Niinomi, Tohoku University, JapanS. Miot and A. Marsano and I. Martin, University Hospital of Basel, SwitzerlandR. Tsaryk, University Medical Center of the Johannes Gutenberg University, Germany and M. Santin, University of Brighton, UK and and E. Dohle and R. E. Unger and C. J. Kirkpatrick, University Medical Center of the Johannes Gutenberg University, GermanyA. Gloria and T. Russo and R. De Santis and L. Ambrosio, Institute of Composite and Biomedical Materials, National Research Council of Italy, ItalyT. H. Smit and M. N. Helder, VU University Medical Centre, The Netherlands
Contributor contact detailsp. xiii
1 Introduction to biomaterials for spinal surgeryp. 1
1.1 Introductionp. 1
1.2 Total disc replacementp. 3
1.3 Nucleus pulposus replacementp. 5
1.4 Materials for spinal applicationsp. 7
1.5 Conclusionsp. 28
1.6 Referencesp. 29
Part 1 Fundamentals of biomaterials for spinal surgeryp. 39
2 An overview of the challenges of bringing a medical device for the spine to the marketp. 41
2.1 Introductionp. 41 I
2.2 Selection and sourcing of materials in medical device developmentsp. 43
2.3 Biocompatibility testingp. 50
2.4 Medical device regulationp. 59
2.5 Conclusionsp. 73
2.6 Acknowledgementp. 74
2.7 Referencesp. 74
3 Introduction to spinal pathologies and clinical problems of the spinep. 78
3.1 Introductionp. 78
3.2 Degenerative spine diseasep. 80
3.3 Spinal traumap. 88
3.4 Spinal deformityp. 97
3.5 Malignancyp. 105
3.6 Infectionp. 108
3.7 Conclusionsp. 109
3.8 Referencesp. 110
4 Forces on the spinep. 114
4.1 Introductionp. 114
4.2 In vivo measured components of spinal loadsp. 115
4.3 In vitro measured spinal load componentsp. 126
4.4 Analytical models for spinal load estimationp. 129
4.5 Recommendations for the simulations of loads for in vitro and numerical studiesp. 133
4.6 Conclusionsp. 137
4.7 Referencesp. 137
5 Finite element modelling of the spinep. 144
5.1 Introductionp. 144
5.2 Functional spine biomechanics and strength of numerical explorationsp. 144
5.3 Geometrical approximations in spine finite element modellingp. 156
5.4 Numerical approximations: accuracy and computational costp. 166
5.5 Constitutive models for the spine tissuesp. 179
5.6 Simulating the mechanical loads on the spinep. 201
5.7 Model verifications and interpretations: the validation concept and quantitative validationp. 207
5.8 Future trends and conclusions: the virtual physiological spinep. 218
5.9 Referencesp. 219
6 Osteobiologic agents in spine surgeryp. 233
6.1 Introductionp. 233
6.2 Bone formation and healingp. 234
6.3 Osteobiologics for spine fusionp. 239
6.4 Bone growth factorsp. 245
6.5 Cellular biologiesp. 251
6.6 Conclusionsp. 256
6.7 Referencesp. 257
Part II Spinal fusion and intervertebral discsp. 263
7 Spine fusion: cages, plates and bone substitutesp. 265
7.1 Introductionp. 265
7.2 Spine fusion: historical concerns and surgical skillsp. 266
7.3 Bone substitutes in spine fusionp. 276
7.4 Bone growth factorsp. 284
7.5 Autologous bone marrowp. 286
7.6 Future trendsp. 287
7.7 Referencesp. 288
8 Artificial intervertebral discsp. 295
8.1 Introductionp. 295
8.2 Structure and function of the intervertebral discp. 296
8.3 The artificial intervertebral disc: design and materialsp. 298
8.4 Fibre-reinforced composite materials: basic principlesp. 301
8.5 Composite biomimetic artificial intervertebral discsp. 303
8.6 Future trends and conclusionsp. 309
8.7 Referencesp. 310
9 Biological response to artificial discsp. 313
9.1 Introductionp. 313
9.2 The healing response to intervertebral disc implantsp. 316
9.3 Infection as a cause of failure of implantsp. 322
9.4 Loosening and the reaction to the products of wear and corrosionp. 324
9.5 Carcinogenicity and genotoxicity of metal implantsp. 346
9.6 Conclusionsp. 347
9.7 Referencesp. 348
Part III Vertebroplasty and scoliosis surgeryp. 363
10 The use of polymethyl methacrylate (PMMA) in neurosurgeryp. 365
10.1 Introduction: a history of polymethyl methacrylate(PMMA)p. 365
10.2 Characteristics of polymethyl methacrylate (PMMA)p. 366
10.3 Preparation of polymethyl methacrylate (PMMA) for use in clinical practicep. 370
10.4 Clinical use of polymethyl methacrylate (PMMA) in neurosurgeryp. 376
10.5 Developments in polymethyl methacrylate (PMMA)p. 380
10.6 Conclusionsp. 382
10.7 Sources of further informationp. 383
10.8 Referencesp. 383
11 Optimising the properties of injectable materials for vertebroplasty and kyphoplastyp. 385
11.1 Introductionp. 385
11.2 Polymethyl methacrylate (PMMA) based bone cementsp. 390
11.3 Calcium phosphate and calcium sulfate based bone cementsp. 396
11.4 Conclusionsp. 399
11.5 Referencesp. 399
12 Injectable calcium phosphates for vertebral augmentationp. 404
12.1 Introductionp. 404
12.2 Polymethyl methacrylate (PMMA)p. 405
12.3 Calcium phosphate cementsp. 406
12.4 Conclusionsp. 410
12.5 Referencesp. 411
13 Composite injectable materials for vertebroplastyp. 414
13.1 Introduction: a background on the use of composites in vertebroplastyp. 414
13.2 Properties of composites for vertebroplastyp. 416
13.3 Further development in composite injectable materialsp. 425
13.4 Conclusionsp. 428
13.5 Referencesp. 428
14 Scoliosis implants' surgical requirementsp. 432
14.1 Introductionp. 432
14.2 Definition of scoliosisp. 435
14.3 Management of scoliosisp. 441
14.4 eneral principles for spinal fusionp. 448
14.5 Outcomes in scoliosis surgeryp. 451
14.6 Future development of biomechanical implantsp. 455
14.7 Conclusionsp. 458
14.8 Sources of further informationp. 458
14.9 Referencesp. 458
15 Shape memory, superelastic and low Young's modulus alloysp. 462
15.1 Introductionp. 462
15.2 Fundamental characteristics of shape memory and superelastic alloysp. 463
15.3 Low Young's modulus alloysp. 479
15.4 Metals required for spinal surgeryp. 480
15.5 Conclusionsp. 486
15.6 Acknowledgementsp. 486
15.7 Referencesp. 486
Part IV Regenerative medicine in the spinep. 491
16 Cell-based tissue engineering approaches for disc regenerationp. 493
16.1 Introductionp. 493
16.2 Rationale behind the use of cellsp. 494
16.3 Choice of cell type (not including mesenchymalstem cells)p. 498
16.4 Current issues to be addressedp. 500
16.5 Future trends and conclusionsp. 503
16.6 Sources of further informationp. 505
16.7 Referencesp. 506
17 Angiogenesis control in spine regenerationp. 510
17.1 Introductionp. 510
17.2 The role and the mechanisms of angiogenesisp. 511
17.3 Physiological and pathological vascularisation of different intervertebral disc (IVD) histological compartmentsp. 514
17.4 Strategies to promote angiogenesis in tissue regenerationp. 517
17.5 Angiogenesis inhibition in intervertebral disc (IVD)p. 522 regenera
17.6 Future trendsp. 528
17.7 Sources of further informationp. 529
17.8 Acknowledgementsp. 530
17.9 Referencesp. 530
18 Stem cells for disc regeneration536M. J. Loughran and J. A. Hunt, University of Liverpool, UK
18.1 Introductionp. 536
18.2 Tissue engineering solutions for intervertebral disc (IVD) diseasep. 539
18.3 Mesenchymal stem cells (MSC) .and regeneration of the intervertebral disc (IVD)p. 541
18.4 Regeneration of the annulusp. 551
18.5 use of scaffolds with mesenchymal stem cells (MSC) for intervertebral disc (IVD) regenerationp. 552
18.6 Future trendsp. 554
18.7 Conclusionsp. 556
18.8 Referencesp. 557
19 Nucleus regenerationp. 563
19.1 Introductionp. 563
19.2 The intervertebral disc: anatomy, structure and functionp. 565
19.3 Mechanics-biology interrelationp. 566
19.4 Annulus, nucleus and entire intervertebraldisc: the tissue engineering approachp. 567
19.5 Conclusionsp. 576
19.6 Referencesp. 576
20 In vivo models of regenerative medicine in the spinep. 582
20.1 Introductionp. 582
20.2 Selecting an animal modelp. 584
20.3 Intervertebral spinal fusionp. 589
20.4 Degenerative disc diseasep. 592
20.5 Future trends and conclusionsp. 597
20.6 Acknowledgementsp. 598
20.7 Referencesp. 598
Indexp. 608